PubRank
Search
About
Michael Reich
Author PubWeight™ 170.87
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The landscape of somatic copy-number alteration across human cancers.
Nature
2010
31.88
2
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature
2012
31.78
3
GenePattern 2.0.
Nat Genet
2006
29.07
4
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.
Science
2006
25.99
5
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
Nat Med
2002
14.01
6
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
N Engl J Med
2008
9.20
7
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics.
Proc Natl Acad Sci U S A
2003
6.87
8
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.
Proc Natl Acad Sci U S A
2005
3.75
9
RNA-SeQC: RNA-seq metrics for quality control and process optimization.
Bioinformatics
2012
2.94
10
Comparative gene marker selection suite.
Bioinformatics
2006
2.71
11
GeneCruiser: a web service for the annotation of microarray data.
Bioinformatics
2005
2.59
12
Using GenePattern for gene expression analysis.
Curr Protoc Bioinformatics
2008
1.68
13
Disease gene discovery through integrative genomics.
Annu Rev Genomics Hum Genet
2005
1.51
14
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Eur J Immunol
2008
1.03
15
Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.
J Immunol
2004
1.01
16
Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
J Leukoc Biol
2004
0.94
17
Cathepsin S dominates autoantigen processing in human thymic dendritic cells.
J Autoimmun
2012
0.94
18
GenePattern flow cytometry suite.
Source Code Biol Med
2013
0.93
19
Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells.
J Immunol
2005
0.91
20
A risk-based method for modeling traffic fatalities.
Risk Anal
2007
0.89
21
Range of motion after total hip resurfacing.
Orthopedics
2007
0.89
22
Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels.
J Gen Virol
2008
0.87
23
Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.
Biochem Biophys Res Commun
2008
0.84
24
Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.
Biol Chem
2006
0.84
25
Erratum: Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.
Sci Data
2014
0.83
26
Characterization of legumain.
Biol Chem
2002
0.82
27
Development of an isotope-coded activity-based probe for the quantitative profiling of cysteine proteases.
Bioorg Med Chem Lett
2004
0.81
28
Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro.
Immunology
2007
0.80
29
Was the serine protease cathepsin G discovered by S. G. Hedin in 1903 in bovine spleen?
Acta Biochim Pol
2011
0.79
30
Effects of tetrahydrobiopterin on nitric oxide bioavailability and renal hemodynamics in healthy volunteers.
J Nephrol
2008
0.77
31
Postthaw clotting of peripheral blood stem cell products due to insufficient anticoagulant.
J Clin Apher
2009
0.75
32
[Separation of functions in the System of Social Protection in Health, Mexico 2009: progress and challenges].
Salud Publica Mex
2011
0.75
33
The influence of a whole food vegan diet with Nori algae and wild mushrooms on selected blood parameters.
Clin Lab
2014
0.75
34
LYSOPHOSPHATIDIC ACIDS AND AUTOTAXIN IN RETINAL VEIN OCCLUSION.
Retina
2016
0.75